These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11166903)

  • 41. Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules.
    Eo SK; Gierynska M; Kamar AA; Rouse BT
    J Immunol; 2001 May; 166(9):5473-9. PubMed ID: 11313385
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Duration of protection from live attenuated vs. sub unit HSV-2 vaccines in the guinea pig model of genital herpes: Reassessing efficacy using endpoints from clinical trials.
    Bernstein DI; Cardin RD; Pullum DA; Bravo FJ; Kousoulas KG; Dixon DA
    PLoS One; 2019; 14(3):e0213401. PubMed ID: 30917165
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A role for the CCR5-CCL5 interaction in the preferential migration of HSV-2-specific effector cells to the vaginal mucosa upon nasal immunization.
    Joo S; Suwanto A; Sato A; Nakahashi-Ouchida R; Mori H; Uchida Y; Sato S; Kurashima Y; Yuki Y; Fujihashi K; Kawaguchi Y; Kiyono H
    Mucosal Immunol; 2019 Nov; 12(6):1391-1403. PubMed ID: 31551493
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma.
    Paglia P; Medina E; Arioli I; Guzman CA; Colombo MP
    Blood; 1998 Nov; 92(9):3172-6. PubMed ID: 9787153
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DNA immunization utilizing a herpes simplex virus type 2 myogenic DNA vaccine protects mice from mortality and prevents genital herpes.
    Gebhard JR; Zhu J; Cao X; Minnick J; Araneo BA
    Vaccine; 2000 Mar; 18(17):1837-46. PubMed ID: 10699332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protective immune correlates can segregate by vaccine type in a murine herpes model system.
    Sin JI; Ayyavoo V; Boyer J; Kim J; Ciccarelli RB; Weiner DB
    Int Immunol; 1999 Nov; 11(11):1763-73. PubMed ID: 10545480
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Coexpression of interleukin-2 enhances the immunization effect of a DNA vaccine expressing herpes simplex 1 glycoprotein D.
    Li WR; Niu B; Wang JW; Feng ZJ; Wang DX
    Acta Virol; 2006; 50(4):251-6. PubMed ID: 17177610
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravaginal immunization with viral subunit protein plus CpG oligodeoxynucleotides induces protective immunity against HSV-2.
    Kwant A; Rosenthal KL
    Vaccine; 2004 Aug; 22(23-24):3098-104. PubMed ID: 15297061
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral Vaccination with Attenuated Salmonella typhimurium-Delivered TsPmy DNA Vaccine Elicits Protective Immunity against Trichinella spiralis in BALB/c Mice.
    Wang L; Wang X; Bi K; Sun X; Yang J; Gu Y; Huang J; Zhan B; Zhu X
    PLoS Negl Trop Dis; 2016 Sep; 10(9):e0004952. PubMed ID: 27589591
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Attenuated Salmonella typhimurium as DNA delivery vehicle for DNA-mediated immunization].
    He P; Chen H; Liu JX; Chen SY; Hu BY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):238-42. PubMed ID: 15640857
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulation of cellular responses by plasmid CD40L: CD40L plasmid vectors enhance antigen-specific helper T cell type 1 CD4+ T cell-mediated protective immunity against herpes simplex virus type 2 in vivo.
    Sin JI; Kim JJ; Zhang D; Weiner DB
    Hum Gene Ther; 2001 Jun; 12(9):1091-102. PubMed ID: 11399230
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens.
    Awasthi S; Mahairas GG; Shaw CE; Huang ML; Koelle DM; Posavad C; Corey L; Friedman HM
    J Virol; 2015 Aug; 89(16):8497-509. PubMed ID: 26041292
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of HSV-specific CD4+ Th1 responses and CD8+ cytotoxic T lymphocytes with antiviral activity by vaccination with the HSV-2 mutant ICP10DeltaPK.
    Gyotoku T; Ono F; Aurelian L
    Vaccine; 2002 Jun; 20(21-22):2796-807. PubMed ID: 12034107
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands.
    Eo SK; Lee S; Kumaraguru U; Rouse BT
    Vaccine; 2001 Sep; 19(32):4685-93. PubMed ID: 11535317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dendritic cell vaccination protects mice against lethality caused by genital herpes simplex virus type 2 infection.
    Schön E; Harandi AM; Nordström I; Holmgren J; Eriksson K
    J Reprod Immunol; 2001 May; 50(2):87-104. PubMed ID: 11334992
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens.
    Karem KL; Bowen J; Kuklin N; Rouse BT
    J Gen Virol; 1997 Feb; 78 ( Pt 2)():427-34. PubMed ID: 9018066
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential roles of B cells and IFN-gamma-secreting CD4(+) T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice.
    Harandi AM; Svennerholm B; Holmgren J; Eriksson K
    J Gen Virol; 2001 Apr; 82(Pt 4):845-853. PubMed ID: 11257190
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A mucosal vaccination approach for herpes simplex virus type 2.
    Tirabassi RS; Ace CI; Levchenko T; Torchilin VP; Selin LK; Nie S; Guberski DL; Yang K
    Vaccine; 2011 Jan; 29(5):1090-8. PubMed ID: 21134447
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of the deletion of US2 and US3 from herpes simplex virus type 2 on immune responses in the murine vagina following intravaginal infection.
    Inagaki-Ohara K; Iwasaki T; Watanabe D; Kurata T; Nishiyama Y
    Vaccine; 2001 Oct; 20(1-2):98-104. PubMed ID: 11567752
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vaxfectin-adjuvanted plasmid DNA vaccine improves protection and immunogenicity in a murine model of genital herpes infection.
    Shlapobersky M; Marshak JO; Dong L; Huang ML; Wei Q; Chu A; Rolland A; Sullivan S; Koelle DM
    J Gen Virol; 2012 Jun; 93(Pt 6):1305-1315. PubMed ID: 22398318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.